ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,561.35
1.02%
US Tech 100
19,317.60
1.62%
Dow Jones
40,401.59
0.28%
Brent Oil
81.645
-0.77%
Bitcoin
67,421.26
-1.08%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Immuron Ltd (IMRN)

  7. Immuron Ltd (IMRN) News

IMRN

Immuron (IMRN)

Immuron Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMRN
DateTimeSourceHeadlineSymbolCompany
07/22/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IMRNImmuron Ltd
07/18/20246:14AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
07/15/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
07/15/20248:00AMGlobeNewswire Inc.Immuron announces record Travelan® sales globally, Australia and USANASDAQ:IMRNImmuron Ltd
07/09/20246:09AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
07/02/20246:00AMGlobeNewswire Inc.Immuron requests pre-IND meeting for IMM-529 with FDA filingNASDAQ:IMRNImmuron Ltd
06/05/20246:12AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
05/31/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
05/31/20246:00AMGlobeNewswire Inc.Immuron Board ChangesNASDAQ:IMRNImmuron Ltd
05/31/20246:00AMGlobeNewswire Inc.Immuron CEO Steven Lydeamore to present at Peak Sky HighNASDAQ:IMRNImmuron Ltd
05/03/20246:00AMGlobeNewswire Inc.Immuron Director ResignationNASDAQ:IMRNImmuron Ltd
04/15/20246:00AMGlobeNewswire Inc.Immuron to host Live Virtual EventNASDAQ:IMRNImmuron Ltd
04/10/20246:00AMGlobeNewswire Inc.Immuron Travelan® sales continued strong growthNASDAQ:IMRNImmuron Ltd
03/07/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
03/07/20246:00AMGlobeNewswire Inc.Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the USNASDAQ:IMRNImmuron Ltd
02/28/20248:08AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
02/21/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
02/21/20246:00AMGlobeNewswire Inc.Immuron Presentation Australian Biologics Festival 2024NASDAQ:IMRNImmuron Ltd
02/13/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
02/13/20246:00AMGlobeNewswire Inc.Immuron achieves record Travelan® salesNASDAQ:IMRNImmuron Ltd
02/08/20246:00AMGlobeNewswire Inc.Immuron CEO, Steven Lydeamore Investor Webinar PresentationNASDAQ:IMRNImmuron Ltd
01/16/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
01/16/20246:00AMGlobeNewswire Inc.Immuron achieves record half yearly Travelan® salesNASDAQ:IMRNImmuron Ltd
12/22/20237:21AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
12/22/20236:00AMGlobeNewswire Inc.Immuron Clinical Trials UpdateNASDAQ:IMRNImmuron Ltd
12/04/20236:32AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
12/04/20236:00AMGlobeNewswire Inc.Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical StudyNASDAQ:IMRNImmuron Ltd
11/28/20236:33AMGlobeNewswire Inc.Immuron CEO, Steven Lydeamore Investor Webinar PresentationNASDAQ:IMRNImmuron Ltd
11/28/20236:17AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
11/22/20237:16AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
 Showing the most relevant articles for your search:NASDAQ:IMRN

Your Recent History

FX
BRLKRW
BRL vs KRW
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved